Discovery and pharmacological characterization of N-[2-({2-[(2S)-2-cyanopyrrolidin-1-yl]-2-oxoethyl}amino)-2-methylpropyl]-2-methylpyrazolo[1,5-a]pyrimidine-6-carboxamide hydrochloride (anagliptin hydrochloride salt) as a potent and selective DPP-IV inhibitor

  • Bioorg Med Chem. 2011 Dec 1;19(23):7221-7. doi: 10.1016/j.bmc.2011.09.043.
Noriyasu Kato  1 ,  Mitsuru Oka ,  Takayo Murase ,  Masahiro Yoshida ,  Masao Sakairi ,  Satoko Yamashita ,  Yoshika Yasuda ,  Aya Yoshikawa ,  Yuuji Hayashi ,  Mitsuhiro Makino ,  Motohiro Takeda ,  Yakufu Mirensha ,  Takuji Kakigami
Affiliations
  • 1. Central Research Laboratory, Sanwa Kagaku Kenkyusho, Co. Ltd, 363 Shiosaki, Hokusei-cho, Inabe-city, Mie 511-0406, Japan. [email protected]
PMID: 22019046 DOI: 10.1016/j.bmc.2011.09.043
Abstract

In the course of our program for discovery of novel DPP-IV inhibitors, a series of pyrazolo[1,5-a]pyrimidines were found to be novel DPP-IV inhibitors. We identified N-[2-({2-[(2S)-2-cyanopyrrolidin-1-yl]-2-oxoethyl}amino)-2-methylpropyl]-2-methylpyrazolo[1,5-a]pyrimidine-6-carboxamide hydrochloride (4a) and described its pharmacological profiles.

Products